ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	29/203	167/7206	1.30379780167e-15
ko04621	NOD-like receptor signaling pathway	26/203	157/7206	1.40621010854e-13
ko04060	Cytokine-cytokine receptor interaction	28/203	191/7206	3.54421170726e-13
ko04217	Necroptosis	26/203	178/7206	2.89547758423e-12
ko05168	Herpes simplex infection	26/203	182/7206	4.89289148499e-12
ko05162	Measles	21/203	120/7206	1.21315674886e-11
ko05340	Primary immunodeficiency	11/203	30/7206	2.31492359669e-10
ko05145	Toxoplasmosis	20/203	126/7206	2.41268008819e-10
ko04612	Antigen processing and presentation	15/203	77/7206	2.5233861867e-09
ko04659	Th17 cell differentiation	17/203	106/7206	4.87470199067e-09
ko04380	Osteoclast differentiation	19/203	134/7206	4.93258047587e-09
ko04622	RIG-I-like receptor signaling pathway	13/203	62/7206	1.18262287209e-08
ko05140	Leishmaniasis	14/203	75/7206	1.56379186297e-08
ko05321	Inflammatory bowel disease (IBD)	12/203	56/7206	3.39418943609e-08
ko05152	Tuberculosis	21/203	187/7206	5.14586333274e-08
ko05320	Autoimmune thyroid disease	9/203	29/7206	5.75272232153e-08
ko04658	Th1 and Th2 cell differentiation	15/203	96/7206	5.83517929773e-08
ko04620	Toll-like receptor signaling pathway	15/203	100/7206	1.02310900374e-07
ko04630	Jak-STAT signaling pathway	17/203	132/7206	1.40669633453e-07
ko05330	Allograft rejection	8/203	24/7206	1.72536290672e-07
ko05161	Hepatitis B	19/203	173/7206	3.28720253691e-07
ko04064	NF-kappa B signaling pathway	14/203	96/7206	3.96160187758e-07
ko05150	Staphylococcus aureus infection	9/203	36/7206	4.55605414533e-07
ko04672	Intestinal immune network for IgA production	9/203	37/7206	5.87499272557e-07
ko05133	Pertussis	13/203	87/7206	7.83302620883e-07
ko04623	Cytosolic DNA-sensing pathway	9/203	41/7206	1.50032199999e-06
ko04650	Natural killer cell mediated cytotoxicity	13/203	97/7206	2.78435578585e-06
ko05167	Kaposi's sarcoma-associated herpesvirus infection	18/203	191/7206	6.29369771501e-06
ko05332	Graft-versus-host disease	6/203	18/7206	6.49516214572e-06
ko04660	T cell receptor signaling pathway	14/203	124/7206	8.98567491693e-06
ko04145	Phagosome	16/203	162/7206	1.16089202329e-05
ko05160	Hepatitis C	15/203	153/7206	2.39979062174e-05
ko04668	TNF signaling pathway	13/203	120/7206	2.95924921375e-05
ko05323	Rheumatoid arthritis	11/203	89/7206	3.60686912856e-05
ko04640	Hematopoietic cell lineage	9/203	64/7206	6.72893980987e-05
ko05142	Chagas disease (American trypanosomiasis)	13/203	130/7206	6.90019533004e-05
ko05310	Asthma	5/203	17/7206	7.92835838425e-05
ko05416	Viral myocarditis	8/203	55/7206	0.000134826910586
ko04062	Chemokine signaling pathway	16/203	201/7206	0.000161782406127
ko00120	Primary bile acid biosynthesis	5/203	20/7206	0.0001853972951
ko04940	Type I diabetes mellitus	6/203	32/7206	0.000228000221059
ko04210	Apoptosis	14/203	180/7206	0.000527568116011
ko03050	Proteasome	7/203	54/7206	0.00073096207963
ko04662	B cell receptor signaling pathway	9/203	88/7206	0.000779344767129
ko05144	Malaria	6/203	45/7206	0.0015116428617
ko05166	HTLV-I infection	18/203	292/7206	0.00162080221194
ko04080	Neuroactive ligand-receptor interaction	3/203	423/7206	0.0035239439266
ko04514	Cell adhesion molecules (CAMs)	10/203	130/7206	0.00355840778174
ko04610	Complement and coagulation cascades	7/203	79/7206	0.00662475613735
ko00590	Arachidonic acid metabolism	5/203	52/7206	0.0150103004214
ko05034	Alcoholism	1/203	238/7206	0.0152213703257
ko01524	Platinum drug resistance	6/203	76/7206	0.0197998560833
ko05146	Amoebiasis	7/203	99/7206	0.0212998361949
ko05020	Prion diseases	4/203	40/7206	0.025325268323
ko00140	Steroid hormone biosynthesis	4/203	41/7206	0.0274633152292
ko05131	Shigellosis	6/203	82/7206	0.0276426029506
ko04020	Calcium signaling pathway	2/203	265/7206	0.0353369353804
ko04657	IL-17 signaling pathway	6/203	87/7206	0.0355662239925
ko04670	Leukocyte transendothelial migration	9/203	151/7206	0.0392579004333
ko04215	Apoptosis - multiple species	4/203	47/7206	0.042510307235
ko05169	Epstein-Barr virus infection	11/203	206/7206	0.0489971250845